Indian pharmaceutical stocks witnessed a decline after US President Donald Trump’s warning about imposing tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, with leading firms such as Gland Pharma and Sun Pharma registering notable losses. Trump’s remarks emphasized the desire to encourage pharmaceutical companies to relocate manufacturing to the United States using tariffs, which could affect India’s significant generic drug exports to the US.